Banyu Pharmaceutical Confirms Efficacy of Propecia in Long-term Administration.Tokyo, Japan, May 30, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - On May 29, Banyu Pharmaceutical announced that the results of its recent trial of Propecia, an agent for the treatment of androgenetic alopecia androgenetic alopecia n. 1. See male pattern baldness. 2. A condition of hair loss in women similar to male pattern baldness, but beginning later in life and less severe. (AGA), have been published in the May 16 issue of Japanese Journal of Clinical Dermatology, an academic dermatology journal. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the journal, the company has confirmed the safety and efficacy of Propecia Tablet 1mg in a 3-year administration. Propecia (finasteride Finasteride Definition Finasteride is a drug that belongs to the class of androgen inhibitors, which means that it blocks the production of male sex hormones. It is sold in the United States and Canada under the brand names Proscar and Propecia. ), which was developed by Merck & Co., is indicated for the treatment of male pattern hair loss on the vertex and anterior mid-scalp area. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion